A comment from a radiotherapeutic point of view regarding the ASCO guidelines on the role of bisphosphonates in breast cancer.
V E
VE
Kouloulias
C
C
Dardoufas
J
J
Kouvaris
C
C
Gennatas
L
L
Vlahos
D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary* / Q000628:therapy*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D004164:Diphosphonates